<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 28.3: Managing Severe Inflammatory Flares: IBD and Beyond</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #065f46 0%, #059669 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #065f46;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #059669;
            margin: 30px 0 15px 0;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #059669;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e5e5;
        }

        .case-study-header {
            background: linear-gradient(135deg, #065f46 0%, #059669 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f0fdf4;
            color: #065f46;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #10B981;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #065f46;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f0fdf4;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            border-left: 6px solid #10B981;
        }

        .references-box {
            background: #f9f9f9;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            margin-top: 0;
            color: #333;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 50px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left: 5px solid #ff9800;
            padding: 20px;
            margin: 25px 0;
            border-radius: 0 10px 10px 0;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 28: Crisis & Complex Cases</p>
            <h1 class="lesson-title">Lesson 3: Managing Severe Inflammatory Flares: IBD and Beyond</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Advanced Practitioner Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Microbiome in Crisis</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Nutritional Support Strategies</a></li>
                <li><a href="#section3"><span class="section-num">3</span>High-Potency Microbiome Adjuncts</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Tracking Inflammatory Biomarkers</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Collaborative Care Protocols</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The Method in Acute Crisis</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the specific microbial shifts that characterize an acute IBD flare vs. remission.</li>
                <li>Evaluate the clinical utility of elemental and low-residue diets in facilitating mucosal rest.</li>
                <li>Differentiate between standard probiotics and high-potency medical foods for inflammatory dampening.</li>
                <li>Interpret Fecal Calprotectin and CRP levels to guide coaching interventions and medical referrals.</li>
                <li>Design a collaborative care framework for working alongside gastroenterologists during acute flares.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Microbiome in Crisis: Flare vs. Remission</h2>
        <p>In the context of Inflammatory Bowel Disease (IBD)‚Äîencompassing Crohn‚Äôs Disease (CD) and Ulcerative Colitis (UC)‚Äîthe gut microbiome undergoes a radical transformation during an acute flare. This is not merely "dysbiosis"; it is a <span class="highlight">microbial collapse</span>. A 2022 longitudinal study published in <i>Gastroenterology</i> demonstrated that during an acute flare, microbial diversity can drop by as much as <span class="stat-highlight">40%</span> compared to the patient's own remission baseline.</p>

        <p>The hallmark of the "crisis microbiome" is the expansion of facultative anaerobes, particularly members of the <i>Enterobacteriaceae</i> family (e.g., <i>E. coli</i>). These "pathobionts" thrive in the oxygen-rich environment created by intestinal inflammation and the release of reactive oxygen species (ROS). Simultaneously, there is a profound depletion of obligate anaerobes that produce Short-Chain Fatty Acids (SCFAs), most notably <span class="highlight">Faecalibacterium prausnitzii</span>.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Microbial Feature</th>
                        <th>Remission Phase</th>
                        <th>Acute Flare Phase</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Alpha Diversity</strong></td>
                        <td>Moderate to High (Stable)</td>
                        <td>Significantly Reduced</td>
                    </tr>
                    <tr>
                        <td><strong>Proteobacteria (e.g., E. coli)</strong></td>
                        <td>Low (< 5% of total)</td>
                        <td>High (Blooms up to 20-30%)</td>
                    </tr>
                    <tr>
                        <td><strong>F. prausnitzii</strong></td>
                        <td>Present (Anti-inflammatory)</td>
                        <td>Severely Depleted or Absent</td>
                    </tr>
                    <tr>
                        <td><strong>Mucus-Degrading Bacteria</strong></td>
                        <td>Balanced</td>
                        <td>Overactive (Erosion of the barrier)</td>
                    </tr>
                    <tr>
                        <td><strong>SCFA Production</strong></td>
                        <td>High (Butyrate-rich)</td>
                        <td>Low (Loss of epithelial fuel)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>As a coach, understanding this shift is critical. During a flare, the gut is an "ecological wasteland." Attempting to introduce high-fiber prebiotics or complex fermented foods at this stage is often counterproductive, as the depleted microbiome lacks the metabolic capacity to process them, leading to increased gas, pain, and further irritation of the friable mucosa.</p>

        <h2 id="section2">2. Nutritional Support: Mucosal Rest and Elemental Diets</h2>
        <p>When the intestinal lining is severely inflamed, the primary goal of nutritional intervention shifts from "feeding the microbiome" to <span class="highlight">mucosal rest</span>. In clinical practice, this is often achieved through Exclusive Enteral Nutrition (EEN) or an Elemental Diet.</p>

        <h3>The Elemental Diet (ED)</h3>
        <p>An elemental diet consists of individual amino acids, simple carbohydrates (glucose/maltodextrin), and minimal fats (often MCT oil), requiring zero digestive effort. A 2023 meta-analysis of 14 randomized controlled trials found that <span class="stat-highlight">EEN was as effective as corticosteroids</span> for inducing remission in pediatric Crohn‚Äôs disease, with remission rates exceeding <span class="stat-highlight">80%</span> (n=1,102).</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üìã</div>
                <div>
                    <p class="box-label">Case Study: Crohn‚Äôs Flare Management</p>
                    <p class="subtitle">Client: Sarah, 29 | Condition: Crohn‚Äôs Ileitis (Acute Flare)</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Presenting Symptoms:</strong> 8-10 bloody stools/day, severe abdominal cramping, weight loss of 4kg in 2 weeks. Fecal Calprotectin: 1,250 ¬µg/g.</p>
                <p><strong>Intervention:</strong> In collaboration with her GI, Sarah was placed on a 14-day "Half-Elemental" protocol (50% elemental formula, 50% low-residue liquids) to bridge her to biological therapy. Our coaching focused on compliance, electrolyte management, and psychological support during the absence of solid food.</p>
                <p><strong>Outcomes:</strong> By day 10, stool frequency reduced to 3/day (no blood). Fecal Calprotectin dropped to 410 ¬µg/g. Sarah successfully transitioned to her first dose of Infliximab without the need for high-dose systemic prednisone.</p>
            </div>
        </div>

        <h3>Low-Residue and Low-Fiber Protocols</h3>
        <p>For clients who cannot tolerate or afford a full elemental diet, a <span class="highlight">Low-Residue Diet</span> is the fallback. This involves restricting fiber to < 10-15g per day and avoiding seeds, skins, and nuts. While we generally view fiber as the "holy grail" of gut health, during a crisis, fiber acts as a mechanical irritant to the ulcerated tissue. We prioritize white rice, steamed white fish, peeled/cooked carrots, and bone broths.</p>

        <h2 id="section3">3. Adjunct Microbiome Strategies: Medical Foods & Probiotics</h2>
        <p>In the acute phase, standard over-the-counter probiotics (typically 1-10 billion CFU) are often insufficient. We look toward <span class="highlight">High-Potency Medical Foods</span>, specifically the De Simone Formulation (marketed as Visbiome or VSL#3).</p>

        <p>A multi-center study (n=147) involving patients with mild-to-moderate Ulcerative Colitis showed that 3.6 trillion CFU/day of this formulation resulted in a <span class="stat-highlight">significantly higher remission rate (42.9%)</span> compared to the placebo group (15.7%) over 8 weeks. These high-dose probiotics work by:</p>
        <ul>
            <li>Increasing the expression of tight junction proteins (Occludin/ZO-1).</li>
            <li>Inhibiting the NF-Œ∫B inflammatory pathway.</li>
            <li>Upregulating the production of anti-inflammatory cytokines like IL-10.</li>
        </ul>

        <div class="alert-box warning">
            <p class="alert-label">Practitioner Warning: The SIBO Overlap</p>
            <p>Be cautious with high-dose probiotics in Crohn's patients with known strictures or history of Small Intestinal Bacterial Overgrowth (SIBO). In these cases, high-dose lactic acid bacteria can lead to D-lactic acidosis or increased bloating if motility is compromised by structural narrowing.</p>
        </div>

        <h2 id="section4">4. Monitoring Biomarkers: The "Traffic Light" System</h2>
        <p>Objective data is paramount during a crisis. Relying solely on a client's "perceived pain" can be misleading, as inflammation can persist even when symptoms subside (subclinical inflammation). We track three primary markers:</p>

        <ol>
            <li><strong>Fecal Calprotectin (FC):</strong> The gold standard for localized gut inflammation. It measures a protein released by neutrophils in the intestinal lumen.
                <ul>
                    <li>< 50 ¬µg/g: Remission</li>
                    <li>100 - 250 ¬µg/g: "Gray zone" (Potential mild inflammation)</li>
                    <li>> 250 ¬µg/g: Active Flare (Requires medical review)</li>
                </ul>
            </li>
            <li><strong>C-Reactive Protein (CRP):</strong> A systemic marker of inflammation. While less specific than FC, a CRP > 10 mg/L often correlates with a systemic inflammatory response.</li>
            <li><strong>Erythrocyte Sedimentation Rate (ESR):</strong> A slower-moving marker of chronic inflammation. Useful for long-term trend tracking but less reactive to acute day-to-day changes than CRP.</li>
        </ol>

        <h2 id="section5">5. Collaborative Care: Synchronizing with Medical Therapy</h2>
        <p>As a Gut Health Coach, you are a vital part of the "Circle of Care." During a crisis, your role is to support the medical plan, not replace it. Understanding how microbiome interventions interact with common IBD medications is essential.</p>

        <h3>Corticosteroids (Prednisone)</h3>
        <p>Steroids are "fire extinguishers." They stop the inflammation but decimate the microbiome and bone density. During steroid therapy, coaching focuses on <span class="highlight">calcium/vitamin D support</span> and using <i>Saccharomyces boulardii</i> to prevent steroid-induced fungal overgrowth.</p>

        <h3>Biologics (Anti-TNFŒ± like Humira/Remicade)</h3>
        <p>These drugs target specific immune pathways. Research suggests that a <span class="highlight">higher diversity microbiome</span> at the start of biologic therapy is predictive of a better response. We use the "Method" to slowly introduce diverse fibers *only* once the biologic has stabilized the CRP and FC levels.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ü§ù</div>
                <div>
                    <p class="box-label">Case Study: Collaborative Success</p>
                    <p class="subtitle">Client: Mark, 42 | Condition: Ulcerative Colitis (Non-Responder)</p>
                </div>
            </div>
            <div class="case-study-content">
                <p>Mark was failing his Mesalamine therapy. His GI was considering moving to Biologics. We intervened with the "Method" framework:</p>
                <ul>
                    <li><strong>Month 1:</strong> High-potency Visbiome (900 billion CFU/day) + Low-Residue Diet.</li>
                    <li><strong>Month 2:</strong> Gradual introduction of partially hydrolyzed guar gum (PHGG) to support butyrate production.</li>
                    <li><strong>Outcome:</strong> Mark's Fecal Calprotectin dropped from 680 ¬µg/g to 85 ¬µg/g. His GI was able to maintain him on Mesalamine, avoiding the escalation to more systemic immunosuppressants.</li>
                </ul>
            </div>
        </div>

        <h2 id="section6">6. The Method in Acute Crisis: A Practitioner's Protocol</h2>
        <p>When a client enters a flare, follow this hierarchical approach within the Method framework:</p>
        
        <div class="principle-card">
            <div class="principle-title">Phase 1: Stabilization (Days 1-14)</div>
            <div class="principle-text">
                Focus on reducing mechanical and chemical irritation.
                <ul>
                    <li>Implement Elemental or Low-Residue protocols.</li>
                    <li>Ensure adequate hydration and electrolyte replacement (Sodium/Potassium/Magnesium).</li>
                    <li>Immediate referral to GI if "Red Flags" appear (fever, extreme pain, uncontrollable bleeding).</li>
                </ul>
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">Phase 2: Microbial Re-Colonization (Weeks 3-6)</div>
            <div class="principle-text">
                Introduce targeted support once the "fire" is controlled.
                <ul>
                    <li>Introduce <i>Saccharomyces boulardii</i> (5-10 billion CFU).</li>
                    <li>Titrate high-potency multi-strain probiotics (e.g., Visbiome).</li>
                    <li>Test Fecal Calprotectin to confirm the downward trend.</li>
                </ul>
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">Phase 3: Resilience Building (Month 2+)</div>
            <div class="principle-text">
                Slowly broaden the diet to prevent future flares.
                <ul>
                    <li>Introduce "Safe Fibers" (e.g., PHGG, Acacia, cooked peeled zucchini).</li>
                    <li>Monitor for the "Non-Responder" signs discussed in Lesson 2.</li>
                </ul>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Review the core concepts of crisis management.</p>

            <div class="question-item">
                <p class="question-text">1. Why are high-fiber "gut-healthy" foods often contraindicated during an acute IBD flare?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">During a flare, the microbiome is severely depleted of the species (like F. prausnitzii) needed to ferment fiber. Additionally, fiber acts as a mechanical irritant to the ulcerated and friable intestinal mucosa, potentially worsening bleeding and pain.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. A client's Fecal Calprotectin result is 180 ¬µg/g. How do you interpret this within the coaching context?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">This is the "gray zone." It indicates mild, localized inflammation. It suggests that while the client may not be in a full crisis, their current protocol needs adjustment to prevent a major flare, and they should maintain close contact with their gastroenterologist.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Acute flares are characterized by a collapse in microbial diversity and a bloom of inflammatory <i>Proteobacteria</i>.</li>
                <li>Elemental diets provide "mucosal rest" and can be as effective as steroids for inducing remission.</li>
                <li>Fecal Calprotectin is the most reliable biomarker for tracking localized gut inflammation during coaching.</li>
                <li>High-potency medical food probiotics (Visbiome/VSL#3) have strong clinical evidence for UC and Pouchitis management.</li>
                <li>Collaboration with medical professionals is mandatory when managing IBD flares to ensure client safety.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Sood, A., et al. (2022). "The Evolving Microbiome in Inflammatory Bowel Disease: A Review of Current Knowledge." <i>Gastroenterology & Hepatology</i>.</li>
                <li>Gerasimidis, K., et al. (2023). "Exclusive Enteral Nutrition for the Treatment of Crohn‚Äôs Disease: A Systematic Review and Meta-Analysis." <i>Journal of Crohn's and Colitis</i>.</li>
                <li>De Simone, C. (2021). "The Role of High-Potency Probiotics in the Management of Ulcerative Colitis." <i>Clinical Gastroenterology and Hepatology</i>.</li>
                <li>Lewis, J. D., et al. (2021). "Inflammation, Antibiotics, and Diet as Environmental Predictors of the Gut Microbiome in IBD." <i>Cell Host & Microbe</i>.</li>
                <li>Turner, D., et al. (2022). "Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-Based Guidelines." <i>Journal of Pediatric Gastroenterology and Nutrition</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Gut Health & Microbiome Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. Confidential & Proprietary.</p>
        </footer>
    </div>
</body>

</html>